✦ LIBER ✦

770 - Phase I dose finding study of irinotecan hydrochloride trihydrate (CPT11) with tomudex (TX.) in patients with 5-FU refractory colorectal cancer

✍ Scribed by D. Cunningham; P. Ross; A. Webb; M. Allen; A. Massey; C. Cote; G. Gruia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of CPT-11 and bolus 5-FU/l

✍ Hiromitsu Fujishima; Ikuo Kikuchi; Osamu Miyanaga; Akira Ueda; Eishi Baba; Kenji 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 194 KB

759 A phase II study of CPT 11 (irinotec

✍ Y. Merrouche; R. Bugat; R. Brunet; J.F. Seitz; T. Conroy; V. Fabre; M. Namer; V. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 269 KB

A phase I, dose-finding study of irinote

✍ Javier Sastre; Luis Paz-Ares; Antonio Carcas; Rosario Alfonso; Cristina Grávalos 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 299 KB

727 A phase II study of CPT 11 (irinotec

✍ J.M. Extra; Ph. Rougier; M. Ychou; J.Y. Douillard; A. Adenis; M. Mousseau; S. As 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 161 KB

A phase I study of combination therapy w

✍ Manabu Shiozawa; Nobuhiro Sugano; Kazuhito Tsuchida; Soichiro Morinaga; Makoto A 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 296 KB

Irinotecan (CPT-11) as first-line monoth

✍ Matilde Navarro García; Ferrán Losa Gaspa; Hermini Manzano Alemany; Pilar García 📂 Article 📅 2002 🏛 Springer Milan 🌐 Spanish ⚖ 148 KB